Dolat Capital: Torrent Pharma Reports Best-Ever Quarter Led By Huge Cost Savings
White-colour pills are displayed in this arranged photograph. (Photographer: Brent Lewin/Bloomberg)

Dolat Capital: Torrent Pharma Reports Best-Ever Quarter Led By Huge Cost Savings

Bookmark
BQ Blue’s special research section collates quality and in-depth equity and economy research reports from across India’s top brokerages. These reports offer BloombergQuint’s subscribers an opportun...